NAIAID awards three contracts to AIDS researchers for SVEU efforts.
The SVEU awards will fund non-human primate resources to support preclinical evaluation of AIDS vaccines. The recipients will use state-of-the-art technologies to evaluate promising candidates for an AIDS vaccine.
AIDS is a serious disease caused by the HIV virus. The virus attacks the human immune system and can trick white blood cells into believing the virus is a helpful organism.
HIV is spread by unprotected sexual intercourse, contaminated blood transfusions, hypodermic needles and from mother to child during birth. HIV originally came from west-central Africa in the mid twentieth century.
AIDS does not have a vaccine or cure, but can be contained with the use of numerous drugs. These drugs are a temporary, and expensive, solution to the AIDS problem.
Advance BioScience Laboratories, Inc., Bioqual, Inc., and Tulane University each received a base award of $100,000 and will be unable to receive more than $80,426,435 from their SVEU contracts.
The contract awards will help boost the labs and facilities of the three recipients.